These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 15537453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z, Simcock J.
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D, Harries A, Getahun H.
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, PharmAccess African Studies to Evaluate Resistance Programme.
    Antivir Ther; 2008 Aug; 13(5):625-39. PubMed ID: 18771046
    [Abstract] [Full Text] [Related]

  • 15. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X.
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa.
    Sellier P, Clevenbergh P, Ljubicic L, Simoneau G, Evans J, Delcey V, Diemer M, Bendenoun M, Mouly S, Bergmann JF.
    Clin Infect Dis; 2006 Sep 01; 43(5):654-7. PubMed ID: 16886162
    [Abstract] [Full Text] [Related]

  • 20. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.
    Antivir Ther; 2006 Sep 01; 11(1):63-72. PubMed ID: 16518961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.